Benzinga | Nov 8, 2021 07:45AM EST

Black Diamond Therapeutic Q3 EPS $(0.97) Down From $(0.50) YoY

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.97) per share. This is a 94 percent decrease over losses of $(0.50) per share from the same period last year.